The U.S. Food and Drug Administration reported receiving several adverse events following the administration of an affected lot “potentially subpotent” L-Citrulline.
L-Citrulline is used to treat urea cycle disorders, and subpotent levels of L-Citrulline can cause potentially life-threatening high levels of ammonia, according to an FDA report.
More Articles on Recalls:
Ben Venue Laboratories Recalls 10% Acetylcysteine Solution
FDA Recalls Covidien’s Puritan Bennett 840 Ventilator
FDA Recalls Faulty Antimicrobial Hospital Safety Showers
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.